Bausch & LombBLCO +2.58%77 Interest Coverage is 0.61 as of Mar. 2026, which is 100% below its 10-year median of 5,000.76. GuruFocus rates BLCO with a GF Score™ of 77/100 and a GF Value™ of $18.29 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 468 Medical Devices & Instruments companies, Bausch & Lomb ranks worse than 96.15% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Bausch & Lomb's
Operating Income
for the
three
months ended in Mar. 2026 was $59 Mil. Bausch & Lomb's Interest Expense for the
three
months ended in Mar. 2026 was $-97 Mil.
Bausch & Lomb's interest coverage for the quarter that ended in Mar. 2026 was 0.61.
The higher the ratio, the stronger the company's financial strength is.
Warning Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Bausch & Lomb Corps earnings cannot cover its interest expense. If the situation continues, the company may have to issue more debt.
The historical rank and industry rank for Bausch & Lomb's Interest Coverage or its related term are showing as below:
BLCO'
s Interest Coverage Range Over the Past 10 Years
Min: 0.45 Med: 5000.76 Max: No Debt
Current: 0.73
BLCO's Interest Coverage is ranked worse than 96.15% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 15.71
vs BLCO: 0.73
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Bausch & Lomb Interest Coverage Related Terms
Bausch & Lomb Interest Coverage Historical Data
* Premium members only.
The historical data trend for Bausch & Lomb's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BLCO vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Bausch & Lomb's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bausch & Lomb Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Bausch & Lomb's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bausch & Lomb (BLCO) has a Interest Coverage of 0.61 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Bausch & Lomb and its competitors. This is 100% below median its historical median of 5,000.76. Over the past decade, Bausch & Lomb's Interest Coverage has ranged from 0.45 to 10,000.00. According to the industry distribution chart, Bausch & Lomb ranks #450 out of 468 companies in the Medical Devices & Instruments industry, placing it in the top 96.2%.
Is Bausch & Lomb's Interest Coverage too high?
Bausch & Lomb's current Interest Coverage of 0.61 is 100% below median its 10-year median of 5,000.76. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 10,000.00. The Medical Devices & Instruments industry median Interest Coverage is 15.71. Bausch & Lomb's value of 0.61 is 96.1% below this industry median. Based on the distribution chart, Bausch & Lomb ranks #450 out of 468 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bausch & Lomb has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bausch & Lomb's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bausch & Lomb ranks #450 out of 468 companies for Interest Coverage. This places Bausch & Lomb in the lower half of its industry. The industry median Interest Coverage is 15.71. Bausch & Lomb's value of 0.61 is 96.1% below this benchmark. Historically, Bausch & Lomb's own Interest Coverage has ranged from 0.45 to 10,000.00 over the past decade. While the company's 10-year median is 5,000.76 vs. the industry median of 15.71, Bausch & Lomb has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.71, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bausch & Lomb's current Interest Coverage of 0.61 is 96.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Bausch & Lomb and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bausch & Lomb's current Interest Coverage is 0.61, which is 100% below median its own 10-year median of 5,000.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch & Lomb stock overvalued right now?
Based on GuruFocus' analysis, Bausch & Lomb (BLCO) is currently considered Modestly Undervalued. The stock's GF Value™ is $18.29, compared to a current price of $16.32 — trading 10.8% below its estimated fair value. The current Interest Coverage is 0.61, which is 100% below median its 10-year median of 5,000.76 and 96.1% below the Medical Devices & Instruments industry median of 15.71. Bausch & Lomb's overall GF Score™ is 77/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Bausch & Lomb (BLCO), the current Interest Coverage is 0.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bausch & Lomb (BLCO) Overvalued in 2026?
Based on GuruFocus' analysis, Bausch & Lomb stock appears to be undervalued.
The current stock price of $16.32 is trading 10.8% below its estimated GF Value™ of $18.29.
GuruFocus considers Bausch & Lomb to be Modestly Undervalued.
Key valuation signals for BLCO:
Interest Coverage: 0.61 (100% below median its 10-year median of 5,000.76)
GF Value™: $18.29 vs. price of $16.32 (10.8% below fair value)
Industry Position: 96.1% below the Medical Devices & Instruments median (#450 of 468)
No single metric tells the full story. See the BLCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
77GF Score
Get the complete analysis for BLCO
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLCO has been successfully added to your 
